Significance of TP53 Mutational Status-Associated Signature in the Progression and Prognosis of Endometrial Carcinoma

Figure 4

Evaluation of the TP53 mutational status-associated signature in training and validation datasets, as well as in clinical specimens. (a–c) Risk score, survival status, K–M curve, and ROC curve in TCGA; (d–f) ucec_tcga_pan_can_atlas_2018; (g–i) ucec_tcga_pub dataset; (j–l) clinical specimens.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)